IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer

Puja Kachroo, Mi Heon Lee, Ling Zhang, Felicita Baratelli, Gina Lee, Minu K. Srivastava, Gerald Wang, Tonya C. Walser, Kostyantyn Krysan, Sherven Sharma, Steven M. Dubinett, Jay M. Lee

Research output: Contribution to journalArticle

53 Scopus citations

Abstract

Background: Interleukin-27 signaling is mediated by the JAK-STAT pathway via activation of STAT1 and STAT3, which have tumor suppressive and oncogenic activities, respectively. Epithelial-mesenchymal transition (EMT) and angiogenesis are key processes in carcinogenesis. Although IL-27 has been shown to have potent anti-tumor activity in various cancer models, the role of IL-27 in EMT and angiogenesis is poorly understood. In this study, we investigated the role of IL-27 in regulating EMT and angiogenesis through modulation of the STAT pathways in human non-small cell lung carcinoma (NSCLC) cells. Methods. STAT activation following IL-27 exposure was measured in human NSCLC cell lines. Expression of epithelial (E-cadherin, γ-catenin) and mesenchymal (N-cadherin, vimentin) markers were assessed by Western blot analysis. Production of pro-angiogenic factors (VEGF, IL-8/CXCL8, CXCL5) were examined by ELISA. Cell motility was examined by an in vitro scratch and transwell migration assays. Selective inhibitors of STAT1 (STAT1 siRNAs) and STAT3 (Stattic) were used to determine whether both STAT1 and STAT3 are required for IL-27 mediated inhibition of EMT and secretion of angiogenic factors. Results: Our results demonstrate that IL-27 stimulation in NSCLC resulted in 1) STAT1 and STAT3 activation in a JAK-dependent manner, 2) development of epithelial phenotypes, including a decrease in the expression of a transcriptional repressor for E-cadherin (SNAIL), and mesenchymal marker (vimentin) with a reciprocal increase in the expression of epithelial markers, 3) inhibition of cell migration, and 4) reduced production of pro-angiogenic factors. STAT1 inhibition in IL-27-treated cells reversed the IL-27 effect with resultant increased expression of Snail, vimentin and the pro-angiogenic factors. The inhibition of STAT3 activation had no effect on the development of the epithelial phenotype. Conclusion: IL-27 induces mesenchymal to epithelial transition and inhibits the production of pro-angiogenic factors in a STAT1-dominant pathway. These findings highlight the importance of STAT1 in repressing lung carcinogenesis and describe a new anti-tumor mechanism of IL-27.

Original languageEnglish
Article number97
JournalJournal of Experimental and Clinical Cancer Research
Volume32
Issue number1
DOIs
StatePublished - Nov 25 2013

Keywords

  • Angiogenesis
  • Cytokine
  • Epithelial-mesenchymal transition
  • IL-27
  • STAT1
  • STAT3

Fingerprint Dive into the research topics of 'IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer'. Together they form a unique fingerprint.

  • Cite this

    Kachroo, P., Lee, M. H., Zhang, L., Baratelli, F., Lee, G., Srivastava, M. K., Wang, G., Walser, T. C., Krysan, K., Sharma, S., Dubinett, S. M., & Lee, J. M. (2013). IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. Journal of Experimental and Clinical Cancer Research, 32(1), [97]. https://doi.org/10.1186/1756-9966-32-97